Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Appl Microbiol Biotechnol ; 105(10): 4199-4211, 2021 May.
Article in English | MEDLINE | ID: mdl-33950281

ABSTRACT

Aromatic compounds are important molecules which are widely applied in many industries and are mainly produced from nonrenewable sources. Renewable sources such as plant biomass are interesting alternatives for the production of aromatic compounds. Ferulic acid and p-coumaric acid, a precursor for vanillin and p-vinyl phenol, respectively, can be released from plant biomass by the fungus Aspergillus niger. The degradation of hydroxycinnamic acids such as caffeic acid, ferulic acid, and p-coumaric acid has been observed in many fungi. In A. niger, multiple metabolic pathways were suggested for the degradation of hydroxycinnamic acids. However, no genes were identified for these hydroxycinnamic acid metabolic pathways. In this study, several pathway genes were identified using whole-genome transcriptomic data of A. niger grown on different hydroxycinnamic acids. The genes are involved in the CoA-dependent ß-oxidative pathway in fungi. This pathway is well known for the degradation of fatty acids, but not for hydroxycinnamic acids. However, in plants, it has been shown that hydroxycinnamic acids are degraded through this pathway. We identified genes encoding hydroxycinnamate-CoA synthase (hcsA), multifunctional ß-oxidation hydratase/dehydrogenase (foxA), 3-ketoacyl CoA thiolase (katA), and four thioesterases (theA-D) of A. niger, which were highly induced by all three tested hydroxycinnamic acids. Deletion mutants revealed that these genes were indeed involved in the degradation of several hydroxycinnamic acids. In addition, foxA and theB are also involved in the degradation of fatty acids. HcsA, FoxA, and KatA contained a peroxisomal targeting signal and are therefore predicted to be localized in peroxisomes. KEY POINTS: • Metabolism of hydroxycinnamic acid was investigated in Aspergillus niger • Using transcriptome data, multiple CoA-dependent ß-oxidative genes were identified. • Both foxA and theB are involved in hydroxycinnamate but also fatty acid metabolism.


Subject(s)
Aspergillus niger , Coumaric Acids , Aspergillus niger/genetics , Caffeic Acids , Coenzyme A , Fatty Acids , Oxidative Stress
2.
J Appl Microbiol ; 128(3): 735-746, 2020 Mar.
Article in English | MEDLINE | ID: mdl-31674709

ABSTRACT

AIMS: To create an Aspergillus niger mutant with increased tolerance against ferulic acid using evolutionary adaptation. METHODS AND RESULTS: Evolutionary adaptation of A. niger N402 was performed by consecutive growth on increasing concentrations of ferulic acid in the presence of 25 mmol l-1 d-fructose, starting from 0·5 mmol l-1 and ending with 5 mmol l-1 ferulic acid. The A. niger mutant obtained after six months, named Fa6, showed increased ferulic acid tolerance compared to the parent. In addition, Fa6 has increased ferulic acid consumption and a higher conversion rate, suggesting that the mutation affects aromatic metabolism of this species. Transcriptome analysis of the evolutionary mutant on ferulic acid revealed a distinct gene expression profile compared to the wild type. Further analysis of this mutant and the parent strain provided the first experimental confirmation that A. niger converts coniferyl alcohol to ferulic acid. CONCLUSIONS: The evolutionary adaptive A. niger mutant Fa6 has beneficial mutations that increase the tolerance, conversion rate and uptake of ferulic acid. SIGNIFICANCE AND IMPACT OF THE STUDY: This study demonstrates that evolutionary adaptation is a powerful tool to modify micro-organisms towards increased tolerance to harsh conditions, which is beneficial for various industrial applications.


Subject(s)
Aspergillus niger/genetics , Coumaric Acids/metabolism , Evolution, Molecular , Aspergillus niger/metabolism , Coumaric Acids/toxicity , Gene Expression Profiling , Mutation
3.
Clin Exp Immunol ; 200(1): 1-11, 2020 04.
Article in English | MEDLINE | ID: mdl-31853959

ABSTRACT

Carbamylation is a post-translational modification that can be detected on a range of proteins, including immunoglobulin (Ig)G, in several clinical conditions. Carbamylated IgG (ca-IgG) was reported to lose its capacity to trigger complement activation, but the mechanism remains unclear. Because C1q binds with high affinity to hexameric IgG, we analyzed whether carbamylation of IgG affects binding of C1q, hexamerization and complement-dependent cytotoxicity (CDC). Synovial tissues of rheumatoid arthritis (RA) patients were analyzed for the presence of ca-IgG in vivo. Synovial tissues from RA patients were analyzed for the presence of ca-IgG using mass spectrometry (MS). Monomeric or hexameric antibodies were carbamylated in vitro and quality in solution was controlled. The capacity of ca-IgG to activate complement was analyzed in enzyme-linked immunosorbent (ELISAs) and cellular CDC assays. Using MS, we identified ca-IgG to be present in the joints of RA patients. Using in vitro carbamylated antibodies, we observed that ca-IgG lost its capacity to activate complement in both solid-phase and CDC assays. Mixing ca-IgG with non-modified IgG did not result in effective inhibition of complement activation by ca-IgG. Carbamylation of both monomeric IgG and preformed hexameric IgG greatly impaired the capacity to trigger complement activation. Furthermore, upon carbamylation, the preformed hexameric IgG dissociated into monomeric IgG in solution, indicating that carbamylation influences both hexamerization and C1q binding. In conclusion, ca-IgG can be detected in vivo and has a strongly reduced capacity to activate complement which is, in part, mediated through a reduced ability to form hexamers.


Subject(s)
Arthritis, Rheumatoid/immunology , Complement Activation/immunology , Complement C1q/immunology , Immunoglobulin G/immunology , Aged , Amino Acid Sequence , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/metabolism , Arthritis, Rheumatoid/metabolism , Cell Line, Tumor , Complement C1q/metabolism , Cytotoxicity Tests, Immunologic , Enzyme-Linked Immunosorbent Assay , Humans , Immunoglobulin G/chemistry , Immunoglobulin G/metabolism , Male , Mass Spectrometry , Middle Aged , Protein Carbamylation/immunology , Protein Multimerization/immunology , Synovial Fluid/immunology , Synovial Fluid/metabolism , Synovial Membrane/immunology , Synovial Membrane/metabolism
4.
Osteoarthritis Cartilage ; 28(5): 675-684, 2020 05.
Article in English | MEDLINE | ID: mdl-31634584

ABSTRACT

OBJECTIVE: Inflammation and innate immune responses may contribute to development and progression of Osteoarthritis (OA). Chondrocytes are the sole cell type of the articular cartilage and produce extracellular-matrix molecules. How inflammatory mediators reach chondrocytes is incompletely understood. Previous studies have shown that chondrocytes express mRNA encoding complement proteins such as C1q, suggesting local protein production, which has not been demonstrated conclusively. The aim of this study is to explore C1q production at the protein level by chondrocytes. DESIGN: We analysed protein expression of C1q in freshly isolated and cultured human articular chondrocytes using Western blot, ELISA and flow cytometry. We examined changes in mRNA expression of collagen, MMP-1 and various complement genes upon stimulation with pro-inflammatory cytokines or C1q. mRNA expression of C1 genes was determined in articular mouse chondrocytes. RESULTS: Primary human articular chondrocytes express genes encoding C1q, C1QA, C1QB, C1QC, and secrete C1q to the extracellular medium. Stimulation of chondrocytes with pro-inflammatory cytokines upregulated C1QA, C1QB, C1QC mRNA expression, although this was not confirmed at the protein level. Extracellular C1q bound to the chondrocyte surface dose dependently. In a pilot study, binding of C1q to chondrocytes resulted in changes in the expression of collagens with a decrease in collagen type 2 and an increase in type 10. Mouse articular chondrocytes also expressed C1QA, C1QB, C1QC, C1R and C1S at the mRNA level. CONCLUSIONS: C1q protein can be expressed and secreted by human articular chondrocytes and is able to bind to chondrocytes influencing the relative collagen expression.


Subject(s)
Chondrocytes/metabolism , Complement C1q/genetics , Complement C1r/genetics , Complement C1s/genetics , Osteoarthritis, Knee/genetics , RNA, Messenger/metabolism , Animals , Cartilage, Articular/cytology , Collagen Type II/genetics , Collagen Type X/genetics , Gene Expression Regulation , Humans , Mice , Osteoarthritis, Knee/metabolism , Pilot Projects
5.
Lupus ; 28(10): 1255-1260, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31357913

ABSTRACT

INTRODUCTION: C1q is an essential part of the classical pathway of complement activation. Genetic deficiencies, caused by homozygous mutations in one of the C1q genes, are rare and are strongly associated with development of systemic lupus erythematosus (SLE). Here we describe a C1q-deficient patient with a compound heterozygous mutation. MATERIAL AND METHODS: Serum was analysed with enzyme-linked immunosorbent assay (ELISA) and Western blot for the presence of C1q, and DNA and RNA sequencing was performed to identify the mutations and confirm that these were located on different chromosomes. RESULTS: The medical history of the patient includes SLE diagnosis at age 11 years with cerebral involvement at age 13, various infections, osteonecrosis and hemophagocytic syndrome. Using ELISA and Western blot, we confirmed the absence of C1q in the serum of the patient. Using DNA sequencing, two mutations in the C1QC gene were identified: c.100G > A p.(Gly34Arg) and c.205C > T p.(Arg69X). With RNA sequencing we confirmed that the mutations are located on different chromosomes. DISCUSSION: The patient described in this case report has a compound heterozygous mutation in C1QC resulting in C1q deficiency.


Subject(s)
Complement C1q/genetics , Lupus Erythematosus, Systemic/genetics , Mutation , Adult , Female , Homozygote , Humans , Sequence Analysis, DNA , Sequence Analysis, RNA
6.
Clin Exp Immunol ; 188(2): 183-194, 2017 05.
Article in English | MEDLINE | ID: mdl-28249350

ABSTRACT

The complement system is an important part of the innate immune defence. It contributes not only to local inflammation, removal and killing of pathogens, but it also assists in shaping of the adaptive immune response. Besides a role in inflammation, complement is also involved in physiological processes such as waste disposal and developmental programmes. The complement system comprises several soluble and membrane-bound proteins. The bulk of the soluble proteins is produced mainly by the liver. While several complement proteins are produced by a wide variety of cell types, other complement proteins are produced by only a few related cell types. As these data suggest that local production by specific cell types may have specific functions, more detailed studies have been employed recently analysing the local and even intracellular role of these complement proteins. Here we review the current knowledge about extrahepatic production and/or secretion of complement components. More specifically, we address what is known about complement synthesis by cells of the human immune system.


Subject(s)
Complement Activation , Complement System Proteins/biosynthesis , Leukocytes/immunology , Macrophages/immunology , Mast Cells/immunology , Adaptive Immunity , Animals , B-Lymphocytes/immunology , Complement System Proteins/immunology , Humans , Immunity, Innate , Immunologic Factors , Inflammation , Killer Cells, Natural/immunology , Monocytes/immunology , Neutrophils/immunology , T-Lymphocytes/immunology
7.
Clin Exp Allergy ; 45(2): 423-37, 2015 Feb.
Article in English | MEDLINE | ID: mdl-24912986

ABSTRACT

BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is characterised by an exaggerated Th2 response to Aspergillus fumigatus, but the immunological pathways responsible for this effect are unknown. OBJECTIVE: The aim of this study was to decipher the pattern recognition receptors (PRRs) and cytokines involved in the Aspergillus-specific Th2 response and to study Aspergillus-induced responses in healthy controls and ABPA patients. METHODS: Peripheral blood mononuclear cells (PBMCs) were stimulated with heat-killed Aspergillus conidia, various other pathogens, or PRR ligands. PRRs and cytokine pathways were blocked with PRR-blocking reagents, anti-TNF (Etanercept or Adalimumab), IL-1Ra (Anakinra) or IFNγ (IFN-gamma). ELISA and FACS were used to analyse cytokine responses. RESULTS: Aspergillus was the only pathogen that stimulated the Th2 cytokines IL-5 and IL-13, while Gram-negative bacteria, Gram-positive bacteria, Candida albicans, chitin, ß-glucan or Toll-like receptor (TLR) ligands did not. Depletion of CD4(+) cells abolished IL-13 production. Blocking complement receptor 3 (CR3) significantly reduced IL-5 and IL-13, while blocking TLR2, TLR4 or dectin-1 had no effect. ABPA patients displayed increased Aspergillus-induced IL-5 and IL-13 and decreased IFNγ production compared with healthy controls. All biological agents tested showed the capability to inhibit Th2 responses, but also decreased Aspergillus-induced IFNγ. CONCLUSIONS AND CLINICAL RELEVANCE: Aspergillus conidia are unique in triggering Th2 responses in human PBMCs, through a CR3-dependent pathway. ABPA patients display a significantly increased Aspergillus-induced Th2/Th1 ratio that can be modulated by biologicals. These data provide a rationale to explore IFNγ therapy in ABPA as a corticosteroid-sparing treatment option, by dampening Th2 responses and supplementing the IFNγ deficiency at the same time.


Subject(s)
Aspergillosis, Allergic Bronchopulmonary/immunology , Aspergillosis, Allergic Bronchopulmonary/metabolism , Cytokines/metabolism , Receptors, Pattern Recognition/metabolism , Signal Transduction , Th2 Cells/immunology , Th2 Cells/metabolism , Adult , Aged , Antibodies, Fungal/immunology , Aspergillosis, Allergic Bronchopulmonary/drug therapy , Aspergillosis, Allergic Bronchopulmonary/genetics , Aspergillus/immunology , Case-Control Studies , Cytokines/pharmacology , Female , Humans , Immunoglobulin E/immunology , Immunoglobulin G/immunology , Lectins, C-Type/genetics , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/immunology , Leukocytes, Mononuclear/metabolism , Ligands , Macrophage-1 Antigen/metabolism , Male , Middle Aged , Mutation , Phagocytosis/immunology , Receptors, Pattern Recognition/antagonists & inhibitors , T-Lymphocyte Subsets/drug effects , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Th1 Cells/immunology , Th1 Cells/metabolism , Th2 Cells/drug effects , Young Adult
8.
Science ; 292(5518): 914-6, 2001 May 04.
Article in English | MEDLINE | ID: mdl-11340201

ABSTRACT

We report phonon densities of states (DOS) of iron measured by nuclear resonant inelastic x-ray scattering to 153 gigapascals and calculated from ab initio theory. Qualitatively, they are in agreement, but the theory predicts density at higher energies. From the DOS, we derive elastic and thermodynamic parameters of iron, including shear modulus, compressional and shear velocities, heat capacity, entropy, kinetic energy, zero-point energy, and Debye temperature. In comparison to the compressional and shear velocities from the preliminary reference Earth model (PREM) seismic model, our results suggest that Earth's inner core has a mean atomic number equal to or higher than pure iron, which is consistent with an iron-nickel alloy.

9.
J Dairy Sci ; 84(1): 286-91, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11210043

ABSTRACT

Cystic ovarian disease (COD) is one of the most frequently diagnosed gynecological findings in dairy cattle. It causes temporary infertility and is likely to affect reproduction as well as production parameters in cows. The objectives of this study were to investigate the heritability of COD in a Dutch Black and White population and to estimate the genetic and phenotypic relationships with milk production traits. In the data set used, the overall incidence of COD was 7.7% (1204 COD diagnoses in 15,562 lactations). The farm incidence varied between 1.9 and 11.3%. The estimated heritabilities on the underlying and observable scales were 0.102 and 0.087, respectively. The genetic correlations between COD and 305-d milk, fat, and protein yields were 0.345, 0.379, and 0.441, respectively. We concluded that a genetic predisposition for COD exists in Dutch Black and White dairy cattle. The genetic correlations between COD and yield traits indicate that ongoing selection for production will increase the incidence of COD.


Subject(s)
Cattle Diseases/genetics , Ovarian Cysts/veterinary , Animals , Breeding , Cattle , Cattle Diseases/epidemiology , Cattle Diseases/physiopathology , Female , Genetic Predisposition to Disease , Genetic Variation , Incidence , Lactation/genetics , Netherlands/epidemiology , Ovarian Cysts/epidemiology , Ovarian Cysts/genetics , Ovarian Cysts/physiopathology , Phenotype
10.
Science ; 287(5456): 1250-3, 2000 Feb 18.
Article in English | MEDLINE | ID: mdl-10678829

ABSTRACT

The lattice dynamics of the hexagonal close-packed (hcp) phase of iron was studied with nuclear inelastic absorption of synchrotron radiation at pressures from 20 to 42 gigapascals. A variety of thermodynamic parameters were derived from the measured density of phonon states for hcp iron, such as Debye temperatures, Gruneisen parameter, mean sound velocities, and the lattice contribution to entropy and specific heat. The results are of geophysical interest, because hcp iron is considered to be a major component of Earth's inner core.

SELECTION OF CITATIONS
SEARCH DETAIL
...